741 related articles for article (PubMed ID: 17224049)
1. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
Schönfeld M; Barreto Miranda I; Schunk M; Maduhu I; Maboko L; Hoelscher M; Berens-Riha N; Kitua A; Löscher T
Malar J; 2007 Jan; 6():2. PubMed ID: 17224049
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
Mugittu K; Ndejembi M; Malisa A; Lemnge M; Premji Z; Mwita A; Nkya W; Kataraihya J; Abdulla S; Beck HP; Mshinda H
Am J Trop Med Hyg; 2004 Dec; 71(6):696-702. PubMed ID: 15642957
[TBL] [Abstract][Full Text] [Related]
3. Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum.
Osman ME; Mockenhaupt FP; Bienzle U; Elbashir MI; Giha HA
Infect Genet Evol; 2007 Jan; 7(1):52-9. PubMed ID: 16690361
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity.
Alifrangis M; Enosse S; Khalil IF; Tarimo DS; Lemnge MM; Thompson R; Bygbjerg IC; Rønn AM
Am J Trop Med Hyg; 2003 Dec; 69(6):601-6. PubMed ID: 14740875
[TBL] [Abstract][Full Text] [Related]
5. Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine-pyrimethamine as first-line treatment.
Eriksen J; Mwankusye S; Mduma S; Kitua A; Swedberg G; Tomson G; Gustafsson LL; Warsame M
Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):347-53. PubMed ID: 15099990
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
Happi CT; Gbotosho GO; Folarin OA; Akinboye DO; Yusuf BO; Ebong OO; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
[TBL] [Abstract][Full Text] [Related]
7. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
Bamaga OA; Mahdy MA; Lim YA
Malar J; 2015 Dec; 14():516. PubMed ID: 26693691
[TBL] [Abstract][Full Text] [Related]
8. Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran.
Afsharpad M; Zakeri S; Pirahmadi S; Djadid ND
Acta Trop; 2012 Jan; 121(1):13-8. PubMed ID: 22001304
[TBL] [Abstract][Full Text] [Related]
9. Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy.
Madkhali AM; Al-Mekhlafi HM; Atroosh WM; Ghzwani AH; Zain KA; Abdulhaq AA; Ghailan KY; Anwar AA; Eisa ZM
Malar J; 2020 Dec; 19(1):446. PubMed ID: 33267841
[TBL] [Abstract][Full Text] [Related]
10. High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania.
Baraka V; Ishengoma DS; Fransis F; Minja DT; Madebe RA; Ngatunga D; Van Geertruyden JP
Malar J; 2015 Nov; 14():439. PubMed ID: 26542942
[TBL] [Abstract][Full Text] [Related]
11. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
[TBL] [Abstract][Full Text] [Related]
12. Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene.
Alifrangis M; Lusingu JP; Mmbando B; Dalgaard MB; Vestergaard LS; Ishengoma D; Khalil IF; Theander TG; Lemnge MM; Bygbjerg IC
Am J Trop Med Hyg; 2009 Apr; 80(4):523-7. PubMed ID: 19346369
[TBL] [Abstract][Full Text] [Related]
13. Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.
Biswas S
J Postgrad Med; 2004; 50(1):17-20. PubMed ID: 15047993
[TBL] [Abstract][Full Text] [Related]
14. [Monitoring the chemoresistance of Plasmodium falciparum malaria in Yopougon (Abidjan): in vivo study of chloroquine sensitivity and evaluation of pyrimethamine resistance following the analysis of point mutation in the dihydrofolate reductase gene].
Djaman AJ; Basco LK; Mazabraud A
Sante; 2002; 12(4):363-7. PubMed ID: 12626289
[TBL] [Abstract][Full Text] [Related]
15. Emergence of an unusual sulfadoxine-pyrimethamine resistance pattern and a novel K540N mutation in dihydropteroate synthetase in Plasmodium falciparum isolates obtained from Car Nicobar Island, India, after the 2004 Tsunami.
Lumb V; Das MK; Mittra P; Ahmed A; Kumar M; Kaur P; Dash AP; Singh SS; Sharma YD
J Infect Dis; 2009 Apr; 199(7):1064-73. PubMed ID: 19220141
[TBL] [Abstract][Full Text] [Related]
16. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.
Hapuarachchi HC; Dayanath MY; Bandara KB; Abeysundara S; Abeyewickreme W; de Silva NR; Hunt SY; Sibley CH
Am J Trop Med Hyg; 2006 Feb; 74(2):198-204. PubMed ID: 16474070
[TBL] [Abstract][Full Text] [Related]
17. Molecular surveillance of mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum in Ethiopia.
Gebru-Woldearegai T; Hailu A; Grobusch MP; Kun JF
Am J Trop Med Hyg; 2005 Dec; 73(6):1131-4. PubMed ID: 16354825
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.
Nsimba B; Jafari-Guemouri S; Malonga DA; Mouata AM; Kiori J; Louya F; Yocka D; Malanda M; Durand R; Le Bras J
Trop Med Int Health; 2005 Oct; 10(10):1030-7. PubMed ID: 16185238
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under 5-year olds in Brazzaville, Congo.
Ndounga M; Tahar R; Basco LK; Casimiro PN; Malonga DA; Ntoumi F
Trop Med Int Health; 2007 Oct; 12(10):1164-71. PubMed ID: 17956498
[TBL] [Abstract][Full Text] [Related]
20. A molecular epidemiologic study of point mutations for pyrimethamine-sulfadoxine resistance of Plasmodium falciparum isolates from Lao PDR.
Toma H; Imada Y; Vannachone B; Miyagi M; Kobayashi J; Uechi G; Pethuvang R; Manivong K; Phompida S; Sato Y
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):602-4. PubMed ID: 16124424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
